Drug Shortage Report for POTASSIUM PHOSPHATES INJECTION, USP

Last updated on 2022-05-02 History
Report ID 158780
Drug Identification Number 02139545
Brand name POTASSIUM PHOSPHATES INJECTION, USP
Common or Proper name Potassium Phosphates Injection, USP
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) POTASSIUM PHOSPHATE DIBASIC POTASSIUM PHOSPHATE MONOBASIC
Strength(s) 236MG 224MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 50 mL
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-03-01
Estimated end date
Actual end date 2022-04-30
Shortage status Resolved
Updated date 2022-05-02
Company comments On 100% allocation
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2022-05-02 French Compare
v3 2022-05-02 English Compare
v2 2022-04-13 French Compare
v1 2022-04-13 English Compare

Showing 1 to 4 of 4